Patents by Inventor Judith Field

Judith Field has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TAM receptors and TAM receptor ligands in detection and modulation of neuropathological disease
    Patent number: 9139879
    Abstract: Methods, compositions and kits based on TAM receptors, or TAM receptor ligands or agonists are for detection of neuropathological diseases or determination of their progression. The neural diseases include multiple sclerosis or other inflammatory neural disorders that are characterized by demyelination, oligodendrocyte cytotoxicity and microglial activation. These methods include screening cells of a subject where identification of an elevation of expression of a TAM receptor or a change in expression of a TAM receptor ligand indicates the presence of the disease presence or progression. In addition, subjects with such neuropathological diseases can be treated by administering TAM receptor ligands (such as GAS 6 or Protein S) or by administering agonists such as antibodies specific for the TAM receptors; Axl, Mer or Tyro3.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: September 22, 2015
    Assignee: HOWARD FLOREY INSTITUTE
    Inventors: Victoria Mary Perreau, Judith Field, Michele D Binder, Trevor Kilpatrick
  • TAM RECEPTORS AND TAM RECEPTOR LIGANDS IN DETECTION AND MODULATION OF NEUROPATHOLOGICAL DISEASE
    Publication number: 20130309243
    Abstract: Methods, compositions and kits based on TAM receptors, or TAM receptor ligands or agonists are for detection of neuropathological diseases or determination of their progression. The neural diseases include multiple sclerosis or other inflammatory neural disorders that are characterized by demyelination, oligodendrocyte cytotoxicity and microglial activation. These methods include screening cells of a subject where identification of an elevation of expression of a TAM receptor or a change in expression of a TAM receptor ligand indicates the presence of the disease presence or progression. In addition, subjects with such neuropathological diseases can be treated by administering TAM receptor ligands (such as GAS 6 or Protein S) or by administering agonists such as antibodies specific for the TAM receptors; Axl, Mer or Tyro3.
    Type: Application
    Filed: August 19, 2011
    Publication date: November 21, 2013
    Applicant: HOWARD FLOREY INSTITUTE
    Inventors: Victoria Mary Perreau, Judith Field, Michelle D. Binder, Trevor Kilpatrick